EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, cilt.122, sa.5, ss.295-302, 2014 (SCI-Expanded)
Objective: The objective of this study was to evaluate and compare the effects of gliclazidemodified release (gliclazide-MR), metformine (MET) and pioglitazone (PIO) monotherapies on glycemic control and conventional/non-conventional cardiovascular risk factors in patients with newly diagnosed type 2 diabetes mellitus (T2DM).